Original Research
Published on 19 Jul 2024
RAB42 overexpression correlates with poor prognosis, immune cell infiltration and chemoresistance
in Experimental Pharmacology and Drug Discovery
- 2,536 views
- 3 citations
Original Research
Published on 19 Jul 2024
in Experimental Pharmacology and Drug Discovery
Editorial
Published on 18 Jul 2024
in Experimental Pharmacology and Drug Discovery
Mini Review
Published on 18 Jul 2024
in Experimental Pharmacology and Drug Discovery
Review
Published on 17 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 15 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 12 Jul 2024
in Experimental Pharmacology and Drug Discovery
Editorial
Published on 12 Jul 2024
in Experimental Pharmacology and Drug Discovery
Editorial
Published on 12 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 11 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 11 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 10 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 10 Jul 2024
in Experimental Pharmacology and Drug Discovery
Review
Published on 10 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 10 Jul 2024
in Experimental Pharmacology and Drug Discovery
Editorial
Published on 10 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 10 Jul 2024
in Experimental Pharmacology and Drug Discovery